marketsgonewild

Christopher Banks: Driving Success with 79% Year-Over-Year Spring Sales Growth and Expansion Plans for Fall 2022

Christopher Banks: Driving Success with 79% Year-Over-Year Spring Sales Growth and Expansion Plans for Fall 2022 MINNEAPOLIS, Aug. 09, 2022 (GLOBE NEWSWIRE) — iMedia Brands, Inc. (“iMedia” or the “Company”) (NASDAQ: IMBI, IMBIL) Christopher & Banks, a 65-year-old iconic brand, has been on a trajectory of success with a remarkable 79% year-over-year growth in net…

Read More

Breaking News: Infinera Successfully Completes $373.75 Million Convertible Senior Notes Offering and Repurchases $300 Million of 2024 Convertible Notes

Breaking News: Infinera Successfully Completes $373.75 Million Convertible Senior Notes Offering and Repurchases $300 Million of 2024 Convertible Notes SAN JOSE, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) — Infinera (NASDAQ: INFN) announced today the closing of its previously announced offering of 3.75% convertible senior notes due 2028 (the “2028 Notes”) in a private placement to…

Read More

Unlocking the Potential: The Incredible Growth of the Global Distributed Cloud Market in the Next Decade

Unlocking the Potential: The Incredible Growth of the Global Distributed Cloud Market in the Next Decade Introduction As technology continues to advance at a rapid pace, the global distributed cloud market is poised for incredible growth in the next decade. Key companies such as Microsoft Corporation, Verizon Communications Inc., IBM Corporation, and others are playing…

Read More

Breaking News: Chemocentryx Inc. Merger Under Investigation by Bragar Eagel & Squire P.C. – Investors Urged to Take Action!

Breaking News: Chemocentryx Inc. Merger Under Investigation by Bragar Eagel & Squire P.C. Investors Urged to Take Action! New York, Aug. 07, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of ChemoCentryx, Inc. (NASDAQ: CCXI) (“ChemoCentryx”) breached…

Read More

Breaking News: Lexicon’s Public Offering and Private Placement Fully Exercised and Closed – Don’t Miss Out!

Lexicon Pharmaceuticals Announces Additional Shares Issuance The Woodlands, Texas Aug. 05, 2022 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) Lexicon Pharmaceuticals, Inc. made a significant announcement today regarding the issuance and sale of an additional 2,526,540 shares of its common stock. The underwriters have exercised their option to purchase additional shares in connection with…

Read More